Document Detail


Rehabilitation of hypoxemic patients with COPD at low altitude at the Dead Sea, the lowest place on earth.
MedLine Citation:
PMID:  9515826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In patients with COPD, oxygen therapy has been shown to improve exercise capacity and survival. Increase in barometric pressure at low altitude can serve as a simple way to improve arterial oxygenation in hypoxemic patients. We have tried to evaluate the effect of staying at low altitude on arterial oxygenation and exercise performance in patients with COPD. PATIENTS AND METHOD: Eleven patients with COPD (9 male, 2 female) aged 38 to 79 years (mean FEV1, 0.96 L; 36% predicted) with hypoxemia (mean PaO2, 54.2+/-8.9 mm Hg) at Jerusalem (altitude 800 m above sea level) were taken down to the Dead Sea area (altitude 402 m below sea level) for 3 weeks. At both locations we tested arterial blood gases, spirometry, progressive exercise, 6-minute walking distance, and sleep oximetry. The study was repeated 2 weeks after returning to Jerusalem. RESULTS: Spirometry results were unchanged. Mean arterial PaO2 rose from 54.2+/-8.9 mm Hg to 69.5+/-11 at the first week and to 66.6+/-11 at the third week of stay (p<0.001). PaCO2 rose from 43.5+/-9.8 mm Hg to 47.7+/-9 and 49.5+/-8.4 (p<0.006). Six-minute walking distance rose from 337+/-107 m to 449+/-73 and 507+/-91 in the third week (p<0.005). Maximum oxygen consumption (VO2max) rose from 901+/-257 mL/min to 1,099+/-255 and 1,063+/-250 mL/min (p=0.01). Sleep oximetry showed an increase in mean sleep arterial oxygen saturation from 86.0+/-4.3% to 89.9+/-4.2% and 88.3+/-3.0 at 1 and 3 weeks, respectively (p<0.05). Following the return to Jerusalem, arterial gases returned to their baseline levels (PaO2, 52.9+/-9.4 mm Hg) but 6-min walking distance remained significantly high, 453+/-47 (p<0.02), and VO2max remained high as well (1,102+/-357 mL/min), although it did not reach statistical significance. CONCLUSIONS: Decline to low altitude or staving at high oxygen environment improves arterial oxygenation and exercise capacity in hypoxemic patients residing in moderate or high altitude. Low altitude (or pressurized wards) can improve pulmonary rehabilitation of hypoxemic patients with COPD.
Authors:
M R Kramer; C Springer; N Berkman; M Glazer; M Bublil; E Bar-Yishay; S Godfrey
Related Documents :
8514706 - Effects of chronic hypoxia and exercise on plasma erythropoietin in high-altitude resid...
12215956 - Red blood cell profile of elite olympic distance triathletes. a three-year follow-up.
7863836 - The effect of qigong on therapeutic balancing measured by electroacupuncture according ...
16499476 - Effect of acetazolamide on leg endurance exercise at sea level and simulated altitude.
15223886 - Why older australians participate in exercise and sport.
12766246 - Static and dynamic changes in carotid artery diameter in humans during and after strenu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chest     Volume:  113     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-04-03     Completed Date:  1998-04-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  571-5     Citation Subset:  AIM; IM; S    
Affiliation:
Pulmonary Institute, Hadassah University Hospital, Ein Kerem, Hebrew University, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Altitude*
Anoxia / blood,  complications*
Atmospheric Pressure*
Carbon Dioxide / blood
Exercise Test
Exercise Tolerance
Female
Forced Expiratory Volume
Humans
Israel
Lung Diseases, Obstructive / complications,  physiopathology,  rehabilitation*
Male
Middle Aged
Oceans and Seas
Oxygen / blood
Oxygen Consumption
Oxygen Inhalation Therapy
Sleep
Spirometry
Vital Capacity
Chemical
Reg. No./Substance:
124-38-9/Carbon Dioxide; 7782-44-7/Oxygen
Comments/Corrections
Comment In:
Chest. 1998 Sep;114(3):949   [PMID:  9743201 ]
Chest. 1998 Mar;113(3):566-7   [PMID:  9515823 ]
Chest. 1998 Dec;114(6):1795-6   [PMID:  9872231 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in ...
Next Document:  Right and left ventricular dysfunction in patients with severe pulmonary disease.